Healthcare & Biotech

Is Alexion Pharmaceuticals (NASDAQ:ALXN) Stock A Good Investment?

By: BNL Staff - August 21, 2017 2:43 AM

With Soliris prediction through 2018, we explore whether Alexion Pharmaceuticals (NASDAQ:ALXN) is a good investment opportunity.

Also posted in HADE Platform, Members

A Potential Valeant Pharmaceuticals (NYSE:VRX) Catalyst in the Making

By: BNL Staff - August 20, 2017 2:43 AM

Valeant Pharmaceuticals (NYSE:VRX) has a golden opportunity to divest Salix and B&L to cut debt in half. Branded Rx would then drive Valeant stock higher.

Also posted in HADE Platform, Members

Why An ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Buyout Is Likely After Surprisingly Strong Nuplazid Sales

By: BNL Staff - August 8, 2017 2:43 AM

Strong Nuplazid sales confirm that off label usage is very likely, thereby making Acadia Pharmaceuticals (NASDAQ:ACAD) a likely buyout opportunity.

Also posted in HADE Platform, Members, Mergers & Acquisitions

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock: Is It Too Late to Buy?

By: BNL Staff - July 21, 2017 2:43 AM

VRTX stock may have little upside, but a Gilead Sciences (NASDAQ:GILD) buyout of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) could be in play.

Also posted in HADE Platform, Hot Stocks, Members, Mergers & Acquisitions

Rite Aid Corporation Keeps Its Better Half: What’s It Mean For RAD Stock?

By: Brian Nichols - July 18, 2017 2:43 AM

Rite Aid Corporation’s pro forma disclosure of what’s left after the Walgreens deal confirms our previous conclusion, that RAD stock is a no-brainer.

Also posted in Members, Mergers & Acquisitions